The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 236.50
Bid: 237.00
Ask: 238.00
Change: 0.50 (0.21%)
Spread: 1.00 (0.422%)
Open: 235.50
High: 239.50
Low: 235.50
Prev. Close: 236.00
MAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Dec 2023 10:30

RNS Number : 0444W
Mitchells & Butlers PLC
07 December 2023

7 December 2023

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Phil Urban

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mitchells & Butlers plc

b)

LEI

213800JHYNDNB1NS2W10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Mitchells & Butlers plc

GB00B1FP6H53

b)

Nature of the transaction

Grant of a conditional share award under the Mitchells & Butlers 2023 Short-Term Deferred Incentive Plan.

Under the terms of the Company's 2023 Short-Term Deferred Incentive Plan (the STDIP), Phil Urban was granted an award on 6 December 2023 in respect of the year to 30 September 2023 under which part of his annual bonus has been deferred into a conditional award of ordinary shares of the Company (the 'Bonus Shares').

The Remuneration Committee has determined that 50% of the annual bonus awarded will be deferred into Bonus Shares under the terms of the STDIP in accordance with the Remuneration Policy.

The Bonus Shares will be released in two equal tranches, 12 and 24 months after deferral. On release of the Bonus Shares Phil Urban will also receive shares with a market value equal to any aggregate gross dividend paid on the Bonus Shares prior to the release date.

On release, the shares are also subject to post cessation holding requirements as detailed in the Company's Remuneration Policy.

c)

Price(s) and volume(s)

Price

Volume

Nil

121,496

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

6 December 2023

f)

Place of the transaction

n/a

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Tim Jones

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mitchells & Butlers plc

b)

LEI

213800JHYNDNB1NS2W10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Mitchells & Butlers plc

GB00B1FP6H53

b)

Nature of the transaction

Grant of a conditional share award under the Mitchells & Butlers 2023 Short-Term Deferred Incentive Plan.

Under the terms of the Company's 2023 Short-Term Deferred Incentive Plan (the STDIP), Tim Jones was granted an award on 6 December 2023 in respect of the year to 30 September 2023 under which part of his annual bonus has been deferred into a conditional award of ordinary shares of the Company (the 'Bonus Shares').

The Remuneration Committee has determined that 50% of the annual bonus awarded will be deferred into Bonus Shares under the terms of the STDIP in accordance with the Remuneration Policy.

The Bonus Shares will be released in two equal tranches, 12 and 24 months after deferral. On release of the Bonus Shares Tim Jones will also receive shares with a market value equal to any aggregate gross dividend paid on the Bonus Shares prior to the release date.

On release, the shares are also subject to post cessation holding requirements as detailed in the Company's Remuneration Policy.

c)

Price(s) and volume(s)

Price

Volume

Nil

101,667

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

6 December 2023

f)

Place of the transaction

n/a

Mitchells & Butlers plc

LEI no. 213800JHYNDNB1NS2W10

Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Freeman

2

Reason for the notification

a)

Position/status

PDMR

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mitchells & Butlers plc

b)

LEI

213800JHYNDNB1NS2W10

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares in Mitchells & Butlers plc

GB00B1FP6H53

b)

Nature of the transaction

Grant of a conditional share award under the Mitchells & Butlers 2023 Short-Term Deferred Incentive Plan.

Under the terms of the Company's 2023 Short-Term Deferred Incentive Plan (the STDIP), Andrew Freeman was granted an award on 6 December 2023 in respect of the year to 30 September 2023 under which part of his annual bonus has been deferred into a conditional award of ordinary shares of the Company (the 'Bonus Shares').

The Remuneration Committee has determined that 21% of the annual bonus awarded will be deferred into Bonus Shares under the terms of the STDIP.

The Bonus Shares will be released in two equal tranches, 12 and 24 months after deferral. On release of the Bonus Shares Andrew Freeman will also receive shares with a market value equal to any aggregate gross dividend paid on the Bonus Shares prior to the release date.

c)

Price(s) and volume(s)

Price

Volume

Nil

22,547

d)

Aggregated information

- Aggregated volume

- Price

N/A (single transaction)

e)

Date of the transaction

6 December 2023

f)

Place of the transaction

n/a

Enquiries:

Denise Burton

Deputy Company Secretary

0121 498 6514

7 December 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBDLFBXLLBFBZ
Date   Source Headline
2nd Apr 20243:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:30 pmRNSBlock listing Interim Review
28th Mar 20241:00 pmRNSTotal Voting Rights
4th Mar 202412:30 pmRNSDirector/PDMR Shareholding
29th Feb 20242:00 pmRNSTotal Voting Rights
5th Feb 20243:30 pmRNSDirector/PDMR Shareholding
31st Jan 20242:21 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
23rd Jan 202412:16 pmRNSResult of Annual General Meeting
17th Jan 20247:00 amRNSFirst Quarter Trading Update
15th Jan 20241:00 pmRNSNotice of First Quarter Trading Update
8th Jan 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20242:00 pmRNSTotal Voting Rights
22nd Dec 20239:36 amRNSDirectorate Declaration
20th Dec 202312:00 pmRNSAnnual Report 2023
14th Dec 20232:30 pmRNSDirector/PDMR Shareholding
11th Dec 20234:35 pmRNSDirector/PDMR Shareholding
8th Dec 202311:30 amRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirector/PDMR Shareholding
30th Nov 202311:30 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSFULL YEAR RESULTS
24th Nov 202312:00 pmRNSNotice of Final Results
14th Nov 202310:45 amRNSDirector/PDMR Shareholding
13th Nov 20232:30 pmRNSDirector/PDMR Shareholding
31st Oct 20231:00 pmRNSTotal Voting Rights
31st Oct 202310:00 amRNSDirectorate Declaration
16th Oct 20232:00 pmRNSDirector/PDMR Shareholding
9th Oct 20233:46 pmRNSListing Application
2nd Oct 20232:30 pmRNSBlock listing Interim Review
28th Sep 20237:00 amRNSFourth Quarter Trading Update
25th Sep 202312:00 pmRNSNotice of Fourth Quarter Trading Statement
18th Sep 20233:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:20 pmRNSDirector/PDMR Shareholding
15th Sep 20232:15 pmRNSDirector/PDMR Shareholding
31st Aug 20232:32 pmRNSTotal Voting Rights
21st Aug 20232:30 pmRNSDirector/PDMR Shareholding
31st Jul 20231:14 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSThird Quarter Trading Update
24th Jul 20232:50 pmRNSDirector/PDMR Shareholding
21st Jul 202312:06 pmRNSNotice of Third Quarter Trading Update
30th Jun 202310:30 amRNSTotal Voting Rights
26th Jun 202311:15 amRNSDirector/PDMR Shareholding
31st May 20233:15 pmRNSTotal Voting Rights
30th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20237:00 amRNSHalf Year Results
11th May 20233:30 pmRNSNotice of Half Year Results
2nd May 20231:52 pmRNSDirector/PDMR Shareholding
28th Apr 202310:50 amRNSTotal Voting Rights
3rd Apr 20239:47 amRNSDirector/PDMR Shareholding
3rd Apr 20238:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.